TMCI
TMCI
NASDAQ · Health Care

Treace Medical Concepts Inc

$4.51
-0.24 (-5.05%)
As of Aug 15, 2:14 AM ET ·
Financial Highlights (FY 2026)
Revenue
218.63M
Net Income
-60,651,227
Gross Margin
79.8%
Profit Margin
-27.7%
Rev Growth
+14.5%
D/E Ratio
0.64
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 79.8% 79.8% 54.2% 54.2%
Operating Margin -26.7% -24.1% 18.2% 18.5%
Profit Margin -27.7% -26.4% 13.5% 12.7%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 218.63M 190.99M 42.92M 46.18M
Gross Profit 174.49M 152.43M 23.26M 25.03M
Operating Income -58,482,633 -45,980,929 7.80M 8.54M
Net Income -60,651,227 -47,685,947 5.79M 5.86M
Gross Margin 79.8% 79.8% 54.2% 54.2%
Operating Margin -26.7% -24.1% 18.2% 18.5%
Profit Margin -27.7% -26.4% 13.5% 12.7%
Rev Growth +14.5% +14.5% +24.4% -6.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 57.04M 57.04M 8.48M 7.21M
Total Equity 89.61M 89.61M 83.95M 82.42M
D/E Ratio 0.64 0.64 0.10 0.09
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -47,559,771 -39,470,413 10.44M 11.89M
Free Cash Flow 4.81M 4.94M